Hip Osteoarthritis
3
Pipeline Programs
5
Companies
5
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket
On Market (2)
Approved therapies currently available
Competitive Landscape
5 companies ranked by most advanced pipeline stage
MedactaSwitzerland - Castel San Pietro
2 programsMPact CupN/A1 trial
total hip arthroplastyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Novartiszoledronic acid
Anika TherapeuticsCingal
Medactatotal hip arthroplasty
MedactaMPact Cup
CorinMiniHip
Clinical Trials (5)
Total enrollment: 49 patients across 5 trials
Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis
Start: May 2007Est. completion: Jun 201149 patients
Phase 4Completed
A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis
Start: Sep 2020Est. completion: Jun 2023
N/ACompleted
Physical Therapy Following Total Hip Arthroplasty
Start: Jul 2018Est. completion: Oct 2019
N/ACompleted
Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty
Start: Oct 2012Est. completion: Mar 2022
N/ACompleted
Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene
Start: Sep 2012Est. completion: Sep 2022
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space